Radware Schedules Conference Call for Second Quarter 2017 Earnings
Jul 03, 2017 10:00 am UTC| Business
TEL AVIV, Israel, July 03, 2017 -- Radware® (NASDAQ:RDWR), a leading provider of cyber security and application delivery solutions, today announced that it has scheduled its earnings call to discuss its second quarter...
Nexvet Biopharma plc ("Nexvet") Supplement Announcement
Jul 03, 2017 09:30 am UTC| Business
DUBLIN, Ireland, July 03, 2017 -- Nexvet Biopharma (Nasdaq:NVET) today announced the following: On June 2, 2017, Nexvet Biopharma plc (“Nexvet”) filed a definitive proxy statement (the “Definitive Proxy Statement”)...
Web Content Management Market to Reach $9,362.3 Million by 2022: P&S Market Research
Jul 03, 2017 09:30 am UTC| Business
NEW YORK, July 03, 2017 -- According to a new market research report “Global Web Content Management (WCM) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Solution (Digital...
Integrated Passive Device Market to Reach $1,572.3 million by 2023: P&S Market Research
Jul 03, 2017 08:30 am UTC| Business
NEW YORK, July 03, 2017 -- According to a new market research report “Global Integrated Passive Device (IPD) Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insights by Base (Silicon and...
BOURBON: Sustainable reorganization of the major part of the financial debt
Jul 03, 2017 06:46 am UTC| Business
Paris, July 3, 2017 Sustainable reorganization of the major part of the financial debt As a result of the agreements relating to the modification of the conditions precedent to the implementation of the...
Nidec Announces the Status of Own Share Repurchase
Jul 03, 2017 06:30 am UTC| Business
KYOTO, Japan, July 03, 2017 -- Nidec Corporation (TSE:6594) (OTC US:NJDCY) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the...
Jul 03, 2017 06:30 am UTC| Business
Company announcement - No. 23/2017 Zealand initiates first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes First patients enrolled in a multinational...